A global cancer conference has been presented with results of a new vaccine trial to help prevent melanoma reoccurring.
157 patients who had skin tumors removed took part in the research.
70 per cent of patients who were given the vaccine were cancer free after five years, compared to 49 per cent who didn’t.
CEO of Breakthrough Cancer Research, Orla Dolan says the results are extremely promising:
